Clinical Trial Update: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial evaluating zidovudine plus lamivudine for HTLV-I-associated myelopathy (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-i-associated Myelopathy

Drugs mentioned

• Lamivudine (lamivudine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: Imperial College London | Conditions: HTLV-I-associated Myelopathy | Phase 2, Phase 3 | Status: COMPLETED